SCHEMBL19861791

SCHEMBL19861791

CC(C)CCCCOC(=O)Nc1ccc(Cl)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.58
NPC1 O15118 5/20 0.58
RAB9A P51151 5/20 0.58
HPGD P15428 3/20 0.58
L3MBTL1 Q9Y468 2/20 0.58
ALDH1A1 P00352 4/20 0.49
LMNA P02545 2/20 0.49
MAPT P10636 2/20 0.49
BCHE P06276 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
MAPK1 P28482 2/20 0.48
CASP1 P29466 1/20 0.48
KDM4E B2RXH2 1/20 0.48
MCL1 Q07820 1/20 0.48
CHRM2 P08172 1/20 0.47
CHRM4 P08173 1/20 0.47
CHRM5 P08912 1/20 0.47
CHRM1 P11229 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10595749 0.85 LMNA (0.65) SMN1; SMN2NPC1RAB9AHPGDL3MBTL1
SCHEMBL19861792 0.84 RAB9A (0.57) SMN1; SMN2NPC1RAB9AHPGDL3MBTL1
SCHEMBL19861778 0.84 TSHR (0.57) SMN1; SMN2NPC1RAB9AHPGDL3MBTL1
SCHEMBL16374745 0.84 RAB9A (0.67) SMN1; SMN2NPC1RAB9AHPGDL3MBTL1
SCHEMBL21059266 0.82 NPC1 (0.65) SMN1; SMN2NPC1RAB9AHPGDL3MBTL1
SCHEMBL21049600 0.82 NPC1 (0.65) SMN1; SMN2NPC1RAB9AHPGDL3MBTL1
SCHEMBL13329848 0.82 NPC1 (0.65) SMN1; SMN2NPC1RAB9AHPGDL3MBTL1
SCHEMBL12411573 0.82 NPC1 (0.58) SMN1; SMN2NPC1RAB9AHPGDL3MBTL1
SCHEMBL21059157 0.82 RAB9A (0.73) SMN1; SMN2NPC1RAB9AHPGDL3MBTL1
SCHEMBL2092836 0.81 L3MBTL1 (0.56) SMN1; SMN2NPC1RAB9AHPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9890178-B2 Azabenzimidazoles as respiratory syncytial virus antiviral agents JANSSEN SCIENCES IRELAND UC (IE) 2018-02-13 US disclosed